It has been reported that 3.3% of BRCA1/2-negative TNBC patients carried a PV in high- (BARD1, PALB2, and RAD51D) or moderate-risk (TP53, BRIP1, and RAD51C) TNBC susceptibility genes [10]. This evidence concerns the gene RAD51C and acquired polycythemia vera.